2hcj: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /><applet load="2hcj" size="450" color="white" frame="true" align="right" spinBox="true" caption="2hcj, resolution 2.12Å" /> '''"Trypsin-modified El... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2hcj.jpg|left|200px]]<br /><applet load="2hcj" size=" | [[Image:2hcj.jpg|left|200px]]<br /><applet load="2hcj" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="2hcj, resolution 2.12Å" /> | caption="2hcj, resolution 2.12Å" /> | ||
'''"Trypsin-modified Elongation Factor Tu in complex with tetracycline"'''<br /> | '''"Trypsin-modified Elongation Factor Tu in complex with tetracycline"'''<br /> | ||
==Overview== | ==Overview== | ||
Two crystal forms of a complex between trypsin-modified elongation factor | Two crystal forms of a complex between trypsin-modified elongation factor Tu-MgGDP from Escherichia coli and the antibiotic tetracycline have been solved by X-ray diffraction analysis to resolutions of 2.8 and 2.1 A, respectively. In the P2(1) form, cocrystals were grown from a solution mixture of the protein and tetracycline. Six copies of the trypsin-modified EF-Tu-MgGDP-tetracycline complex are arranged as three sets of dimers in the asymmetric unit. In the second crystal form, tetracycline was diffused into P4(3)2(1)2 crystals, resulting in a monomeric complex in the asymmetric unit. Atomic coordinates have been refined to crystallographic R factors of 18.0% for the P2(1) form and 20.0% for the P4(3)2(1)2 form. In both complexes, tetracycline makes significant interactions with the GTPase active site of EF-Tu. The phenoldiketone moiety of tetracycline interacts directly with the Mg(2+), the alpha-phosphate group of GDP and two amino acids, Thr25 and Asp80, which are conserved in the GX(4)GKS/T and DX(2)G sequence motifs found in all GTPases and many ATPases. The molecular complementarity, previously unrecognized between invariant groups present in all GTPase/ATPases and the active moiety of tetracycline, may have wide-ranging implications for all drugs containing the phenoldiketone moiety as well as for the design of new compounds targeted against a broad range of GTPases or ATPases. | ||
==About this Structure== | ==About this Structure== | ||
2HCJ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with MG, NA, SO4, TAC, GDP and GLV as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | 2HCJ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=MG:'>MG</scene>, <scene name='pdbligand=NA:'>NA</scene>, <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=TAC:'>TAC</scene>, <scene name='pdbligand=GDP:'>GDP</scene> and <scene name='pdbligand=GLV:'>GLV</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HCJ OCA]. | ||
==Reference== | ==Reference== | ||
| Line 16: | Line 16: | ||
[[Category: Aorora, A.]] | [[Category: Aorora, A.]] | ||
[[Category: Bergmann, E.]] | [[Category: Bergmann, E.]] | ||
[[Category: Heffron, S | [[Category: Heffron, S E.]] | ||
[[Category: Jurnak, F.]] | [[Category: Jurnak, F.]] | ||
[[Category: Mui, S.]] | [[Category: Mui, S.]] | ||
| Line 29: | Line 29: | ||
[[Category: trypsin-modified ef-tu]] | [[Category: trypsin-modified ef-tu]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:40:32 2008'' | ||